Spero Therapeutics, Inc. - 10-Q Filing
Spero Therapeutics reports Q3 financial results featuring collaboration revenue and ongoing R&D activities related to Tebipenem Pivoxil and SPR-720.
Tickers: $SPRO
More Regulatory news
- AMERICAN BATTERY MATERIALS, INC. - 10-Q Filing
- TALPHERA, INC. - 10-Q Filing
- DiaMedica Therapeutics Inc. - 8-K Filing
- Rallybio Corp - 8-K Filing
- T1 Energy Inc. - 10-Q Filing
- DILLARD'S, INC. - 8-K Filing
- NeuroPace Inc - 10-Q Filing
- Nakamoto Inc. - 10-Q Filing
- SmartStop Self Storage REIT, Inc. - 8-K Filing
- LIQUIDMETAL TECHNOLOGIES INC - 10-Q Filing